drugset / Trial / NCT00309101

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

NCT00309101

Phase 3 Completed 11 enrolled Astellas Pharma Inc
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.

Timeline

Start
2006-02
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule Oral

Indications